ACADEMIC PROCEEDINGS - 18TH BIENNIAL CONGRESS OF THE SOUTH AFRICAN SOCIETY OF NUCLEAR MEDICINE (SASNM) 10TH - 12TH AUGUST 2018

Several imaging modalities have been introduced in recent years to improve screening and staging of breast cancer. High Resolution Breast PET Imaging (BPI) has been approved some years ago and introduced into clinical use as complementary diagnostic to mammography and breast ultrasonography/MR. BPI has higher resolution and a more localized field of view than positron emission tomography–computed tomography (PET-CT) and can be performed on patients to stage a newly diagnosed malignancy but, more importantly, to evaluate therapy response in locally advanced breast cancer and in pre-surgical planning. Review of mammograms together with magnetic resonance or Breast PET images improves detection/recurrence of disease. The best way to evaluate and read a BPI study is based on modelling (morphology) and semi-quantitative FDG uptake